ASX
Imugene Limited
IMU:ASX•Healthcare
Sensitive ASX Announcement
Imugene Commences HER-Vaxx Phase 1b/2 Gastric Cancer Study
Published: 07/11/16, 08:43am (AEST)•2 pages